Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P van Meerbeeck

Showing results (31-40 of 250) with videos related to

Pageof 25
Sort By:
Polskie Archiwum Medycyny Wewnetrznej|June 26, 2008
New American College of Chest Physicians guidelines on mediastinal staging and management of stage IIIA-N2 non-small cell lung cancer: a European perspectiveKurt G Tournoy, Jan P van Meerbeeck
Polskie Archiwum Medycyny Wewnetrznej|December 24, 2010
European guidelines for the management of malignant pleural mesotheliomaEric van Thiel, Jan P van Meerbeeck
Current Opinion in Oncology|February 3, 2007
Neoadjuvant chemotherapy in the treatment of nonsmall-cell lung cancerRebecca De Pauw, Jan P van Meerbeeck
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2013
Surgery in mesothelioma--where do we go after MARS?Birgitta I Hiddinga, Jan P van Meerbeeck
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2004
Screening and diagnosis of NSCLCJ P van Meerbeeck, K G Tournoy
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 27, 2010
The role of EBUS-TBNA for the assessment of Hilar lymph nodesKurt G Tournoy, Jan P van Meerbeeck
Lung Cancer (Amsterdam, Netherlands)|March 17, 2009
Stage IIIA-N2 NSCLC: a review of its treatment approaches and future developmentsJan P van Meerbeeck, Veerle F M Surmont
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 8, 2014
Strengths, weaknesses, and opportunities of diagnostic breathomics in pleural mesothelioma-a hypothesisKevin Lamote, Kristiaan Nackaerts, Jan P van Meerbeeck
European Respiratory Review : an Official Journal of the European Respiratory Society|November 18, 2021
Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysisEline Schillebeeckx, Jan P van Meerbeeck, Kevin Lamote
East African Journal of Public Health|November 10, 2011
Asthma, atopy and COPD in sub-Saharan countries: the challengesS Musafiri, G Joos, J P Van Meerbeeck
Pageof 25

Showing results (31-40 of 250) with videos related to

Sort By:
Pageof 25
Polskie Archiwum Medycyny Wewnetrznej|June 26, 2008
New American College of Chest Physicians guidelines on mediastinal staging and management of stage IIIA-N2 non-small cell lung cancer: a European perspectiveKurt G Tournoy, Jan P van Meerbeeck
Polskie Archiwum Medycyny Wewnetrznej|December 24, 2010
European guidelines for the management of malignant pleural mesotheliomaEric van Thiel, Jan P van Meerbeeck
Current Opinion in Oncology|February 3, 2007
Neoadjuvant chemotherapy in the treatment of nonsmall-cell lung cancerRebecca De Pauw, Jan P van Meerbeeck
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2013
Surgery in mesothelioma--where do we go after MARS?Birgitta I Hiddinga, Jan P van Meerbeeck
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2004
Screening and diagnosis of NSCLCJ P van Meerbeeck, K G Tournoy
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 27, 2010
The role of EBUS-TBNA for the assessment of Hilar lymph nodesKurt G Tournoy, Jan P van Meerbeeck
Lung Cancer (Amsterdam, Netherlands)|March 17, 2009
Stage IIIA-N2 NSCLC: a review of its treatment approaches and future developmentsJan P van Meerbeeck, Veerle F M Surmont
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 8, 2014
Strengths, weaknesses, and opportunities of diagnostic breathomics in pleural mesothelioma-a hypothesisKevin Lamote, Kristiaan Nackaerts, Jan P van Meerbeeck
European Respiratory Review : an Official Journal of the European Respiratory Society|November 18, 2021
Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysisEline Schillebeeckx, Jan P van Meerbeeck, Kevin Lamote
East African Journal of Public Health|November 10, 2011
Asthma, atopy and COPD in sub-Saharan countries: the challengesS Musafiri, G Joos, J P Van Meerbeeck
Pageof 25